Literature DB >> 21697469

SH2-containing inositol 5'-phosphatase inhibits transformation of Abelson murine leukemia virus.

Shawn P Fessler1, Naomi Rosenberg, Linda B Baughn.   

Abstract

v-Abl protein tyrosine kinase encoded by Abelson murine leukemia virus (Ab-MLV) transforms pre-B cells. Transformation requires the phosphatidylinositol 3-kinase (PI3K) pathway. This pathway is antagonized by SH2-containing inositol 5'-phosphatase (SHIP), raising the possibility that v-Abl modulates PI3K signaling through SHIP. Consistent with this, we show that v-Abl expression reduces levels of full-length p145 SHIP in a v-Abl kinase activity-dependent fashion. This event requires signals from the Abl SH2 domain but not the carboxyl terminus. Forced expression of full-length SHIP significantly reduces Ab-MLV pre-B-cell transformation. Therefore, reduction of SHIP protein by v-Abl is a critical component in Ab-MLV transformation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21697469      PMCID: PMC3165847          DOI: 10.1128/JVI.05115-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Gag influences transformation by Abelson murine leukemia virus and suppresses nuclear localization of the v-Abl protein.

Authors:  Chae-Ryun Yi; Naomi Rosenberg
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

2.  Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2.

Authors:  W M Kavanaugh; D A Pot; S M Chin; M Deuter-Reinhard; A B Jefferson; F A Norris; F R Masiarz; L S Cousens; P W Majerus; L T Williams
Journal:  Curr Biol       Date:  1996-04-01       Impact factor: 10.834

Review 3.  Role of SHIP in cancer.

Authors:  Melisa J Hamilton; Victor W Ho; Etsushi Kuroda; Jens Ruschmann; Frann Antignano; Vivian Lam; Gerald Krystal
Journal:  Exp Hematol       Date:  2010-11-04       Impact factor: 3.084

4.  The human SHIP gene is differentially expressed in cell lineages of the bone marrow and blood.

Authors:  S J Geier; P A Algate; K Carlberg; D Flowers; C Friedman; B Trask; L R Rohrschneider
Journal:  Blood       Date:  1997-03-15       Impact factor: 22.113

Review 5.  Inhibitor and activator: dual functions for SHIP in immunity and cancer.

Authors:  William G Kerr
Journal:  Ann N Y Acad Sci       Date:  2010-12-13       Impact factor: 5.691

6.  Tyrosine phosphorylation of SHIP promotes its proteasomal degradation.

Authors:  Jens Ruschmann; Victor Ho; Frann Antignano; Etsushi Kuroda; Vivian Lam; Mariko Ibaraki; Kim Snyder; Connie Kim; Richard A Flavell; Toshiaki Kawakami; Laura Sly; Ali G Turhan; Gerald Krystal
Journal:  Exp Hematol       Date:  2010-03-18       Impact factor: 3.084

7.  The Src homology 2 (SH2) domain of SH2-containing inositol phosphatase (SHIP) is essential for tyrosine phosphorylation of SHIP, its association with Shc, and its induction of apoptosis.

Authors:  L Liu; J E Damen; M R Hughes; I Babic; F R Jirik; G Krystal
Journal:  J Biol Chem       Date:  1997-04-04       Impact factor: 5.157

8.  Inositol phosphatase SHIP1 is a primary target of miR-155.

Authors:  Ryan M O'Connell; Aadel A Chaudhuri; Dinesh S Rao; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

9.  Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells.

Authors:  B J Druker; S Tamura; E Buchdunger; S Ohno; G M Segal; S Fanning; J Zimmermann; N B Lydon
Journal:  Nat Med       Date:  1996-05       Impact factor: 53.440

10.  In vivo association of v-Abl with Shc mediated by a non-phosphotyrosine-dependent SH2 interaction.

Authors:  G D Raffel; K Parmar; N Rosenberg
Journal:  J Biol Chem       Date:  1996-03-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.